OTLK
Outlook Therapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$1.38-0.72%
Price as of Jul 20, 2026
OTLK capital
Outlook Therapeutics, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- -0.94x
- Net debt / equity
- -0.67x
- Debt / assets
- 1.24x
- Debt / EBITDA
- -0.44x
- Net debt / EBITDA
- -0.31x
Liquidity & coverage
- Current ratio
- 0.54x
- Quick ratio
- —
- Cash ratio
- 0.20x
- Interest coverage
- -193.21x
- EBITDA / interest
- -198.01x
- Working capital
- -$18.0M
Cash & dividend
- FCF / debt
- -1.73x
- Cash flow / debt
- -1.73x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.